Therapeutic Advances in Drug Safety

SAGE Publishing

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Therapeutic Advances in Drug Safety is an open-access journal published by SAGE Publishing in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,800 USD. Declared review time at DOAJ: 9 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
SAGE Publishing
ISSN
2042-0986 · 2042-0994
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,800 USD
Articles in DOAJ
365
Declared review time
9 weeks
Declared peer-review model
peer_review

Index listings

  • DOAJ · 2019-06-10
Indexing
DOAJ
APC
2,800 USD
Declared review time (DOAJ)
9 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

365

Most recent article

last month

Average review time (journal-declared via DOAJ)

9weeks

Works in OpenAlex

603

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

64

i10-index

300

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-04
Added to DOAJ
2019-06-10
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
CLOCKSSLOCKSSPMCPortico
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
97%
ORCID iDs in current deposits
97%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101549074
Classification2

Subjects (DOAJ)

Medicine: Therapeutics. Pharmacology

LCC codes

RM1-950

Subject areas

  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmacovigilance and Adverse Drug Reactions
  • Pharmaceutical Practices and Patient Outcomes
  • Pharmaceutical Practices and Patient Outcomes
  • Patient Safety and Medication Errors
  • Patient Safety and Medication Errors
  • Medication Adherence and Compliance
  • Medication Adherence and Compliance
Show all subjects (50)
  • Pharmaceutical studies and practices
  • Pharmaceutical studies and practices
  • Atrial Fibrillation Management and Outcomes
  • Atrial Fibrillation Management and Outcomes
  • Drug-Induced Adverse Reactions
  • Drug-Induced Adverse Reactions
  • Pharmaceutical Economics and Policy
  • Pharmaceutical Economics and Policy
  • Diabetes Treatment and Management
  • Diabetes Treatment and Management
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Pharmacogenetics and Drug Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Antibiotic Use and Resistance
  • Pharmaceutical Quality and Counterfeiting
  • Pharmacogenetics and Drug Metabolism
  • Health Systems, Economic Evaluations, Quality of Life
  • Antibiotic Use and Resistance
  • Pharmaceutical Quality and Counterfeiting
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Electronic Health Records Systems
  • Anesthesia and Sedative Agents
  • Anesthesia and Sedative Agents
  • Electronic Health Records Systems
  • Academic integrity and plagiarism
  • Academic integrity and plagiarism
  • Pharmacological Effects and Toxicity Studies
  • Drug-Induced Hepatotoxicity and Protection
  • Pharmacological Effects and Toxicity Studies
  • Schizophrenia research and treatment
  • Drug-Induced Hepatotoxicity and Protection
  • Schizophrenia research and treatment
  • Antibiotics Pharmacokinetics and Efficacy
  • Advanced Causal Inference Techniques
  • Antibiotics Pharmacokinetics and Efficacy
  • Forensic Toxicology and Drug Analysis
  • Forensic Toxicology and Drug Analysis
  • Advanced Causal Inference Techniques
  • Blood Pressure and Hypertension Studies
  • Blood Pressure and Hypertension Studies

Keywords (DOAJ)

  • drug safety
  • clinical toxicology
  • pharmacology
  • pharmacotherapeutics

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: